Serum cystatin C as a predictor of 90‐day mortality among patients admitted with complications of cirrhosis
Abstract Background and Aim Cystatin C (Cys) is not affected by age, sex, and muscle mass. We evaluated to compare the predictive performance of serum Cys level and model for end‐stage liver disease (MELD) score and developed a new model to predict 90‐day mortality among patients admitted with cirrh...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-05-01
|
| Series: | JGH Open |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jgh3.12543 |